세계의 경피적 관상동맥 인터벤션(PCI) 장치 시장

Global Percutaneous Coronary Intervention (PCI) Devices Market to Reach US$13.8 Billion by 2030

The global market for Percutaneous Coronary Intervention (PCI) Devices estimated at US$9.3 Billion in the year 2023, is expected to reach US$13.8 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Coronary Stents, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the PTCA Catheters segment is estimated at 7.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 5.5% CAGR

The Percutaneous Coronary Intervention (PCI) Devices market in the U.S. is estimated at US$2.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 5.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Percutaneous Coronary Intervention (PCI) Devices Market – Key Trends & Drivers Summarized

How Are Technological Innovations Transforming PCI Devices?

The percutaneous coronary intervention (PCI) devices market has undergone remarkable transformation, driven by technological innovations aimed at improving the safety and efficacy of coronary artery disease treatments. PCI, a minimally invasive procedure used to open narrowed coronary arteries, relies on a variety of devices such as stents, catheters, and balloon angioplasty. Technological advancements have led to the development of drug-eluting stents (DES), which release medication to prevent restenosis (re-narrowing of the arteries), significantly improving long-term outcomes compared to bare-metal stents. Additionally, bioresorbable stents, which dissolve over time, are emerging as a promising alternative, offering the potential to reduce long-term complications. Other innovations, such as intravascular imaging technologies like optical coherence tomography (OCT) and intravascular ultrasound (IVUS), allow for precise visualization of the arteries, enabling more accurate stent placement and reducing procedural risks. The advent of robotics-assisted PCI is also gaining momentum, offering enhanced precision and reduced operator fatigue during complex procedures. These technological advancements are making PCI devices more effective and patient-friendly, thereby driving adoption across healthcare systems globally.

Why Are PCI Devices Becoming Crucial in the Treatment of Coronary Artery Disease?

The growing prevalence of coronary artery disease (CAD), driven by factors such as aging populations, sedentary lifestyles, and rising incidences of diabetes and hypertension, has significantly increased the demand for PCI devices. PCI procedures offer a less invasive alternative to traditional coronary artery bypass graft (CABG) surgery, reducing recovery times and lowering the risk of complications. The high success rates of PCI, coupled with advancements in stent technology and catheter design, have made it a preferred treatment option for both stable angina and acute coronary syndromes like heart attacks. Furthermore, the increasing number of cardiac catheterization labs and the rise in skilled interventional cardiologists worldwide are further boosting the adoption of PCI devices. As healthcare providers focus on improving outcomes for patients with cardiovascular diseases, PCI devices are playing an increasingly critical role in managing and treating CAD, particularly in patients who are high-risk or not ideal candidates for open-heart surgery.

How Are Regulatory Approvals and Market Dynamics Influencing the PCI Devices Market?

Regulatory approvals and evolving healthcare policies are significantly shaping the PCI devices market. Stringent regulatory requirements from agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) ensure that PCI devices meet high standards for safety and efficacy before they are approved for clinical use. Recent approvals of newer-generation drug-eluting stents and bioresorbable vascular scaffolds are further driving market growth, as these devices offer improved outcomes and reduced complication rates. In addition, the rising focus on value-based healthcare is influencing hospitals and cardiology centers to adopt PCI devices that not only improve clinical outcomes but also reduce long-term healthcare costs. The growing emphasis on minimally invasive procedures is also creating opportunities for manufacturers to develop and market innovative PCI devices. Collaborations between device manufacturers and healthcare providers, aimed at conducting clinical trials and developing cutting-edge technologies, are accelerating the pace of product innovation in this competitive market.

What Factors Are Driving Growth in the PCI Devices Market?

The growth in the percutaneous coronary intervention (PCI) devices market is driven by several factors, including technological advancements, the rising prevalence of coronary artery disease, and increasing healthcare infrastructure investments. One of the primary drivers is the ongoing development of drug-eluting stents, bioresorbable stents, and improved catheter technologies, which are significantly enhancing the effectiveness of PCI procedures. Additionally, the global burden of cardiovascular diseases, particularly in aging populations and regions with increasing rates of obesity and diabetes, is leading to higher demand for minimally invasive coronary interventions. Regulatory support for advanced medical devices, along with the growing number of cardiac catheterization labs, is expanding the accessibility of PCI procedures in both developed and emerging markets. Moreover, the shift toward value-based healthcare models, which focus on improving patient outcomes and reducing healthcare costs, is prompting hospitals and clinics to adopt advanced PCI technologies. As the demand for less invasive, more effective treatments for coronary artery disease continues to rise, the PCI devices market is expected to experience sustained growth.

Global Perforating Guns Market – Key Trends & Drivers Summarized

How Are Technological Advancements Impacting the Perforating Guns Market?

Technological advancements are playing a crucial role in revolutionizing the perforating guns market, making oil and gas well perforation more efficient and precise. Perforating guns, essential tools used in well-completion processes, create tunnels between the wellbore and the reservoir, allowing oil or gas to flow into the well. Innovations such as advanced-shaped charges, electronic detonation systems, and addressable switches have significantly improved the efficiency and safety of perforation operations. Advanced-shaped charges are now capable of producing deeper and cleaner perforations, enhancing well productivity while minimizing formation damage. Additionally, electronic perforating systems have replaced traditional mechanical ones, offering improved reliability, precise timing, and real-time control over the detonation process. These systems reduce the risk of misfires and allow for multi-zone perforation in a single run, optimizing operational efficiency. Moreover, innovations in gun design, including modular and reusable perforating guns, are lowering operational costs and increasing the environmental sustainability of well completions. These advancements are driving greater adoption of perforating guns in both onshore and offshore drilling operations.

Why Are Perforating Guns Critical in the Oil and Gas Industry?

Perforating guns play a critical role in the oil and gas industry by enabling the efficient extraction of hydrocarbons from reservoirs. After a well has been drilled, perforating guns are used to penetrate the casing and cement to create channels that connect the wellbore to the oil or gas reservoir. This process is vital for enhancing the flow of hydrocarbons and maximizing well productivity. The versatility of perforating guns makes them indispensable for both conventional and unconventional drilling operations, including hydraulic fracturing (fracking) in shale formations. In offshore operations, where drilling conditions are more challenging, perforating guns designed for high-pressure, high-temperature (HPHT) environments ensure reliable performance and safety. As global demand for oil and gas continues to rise, particularly in emerging economies, the need for efficient and cost-effective well-completion technologies, such as advanced perforating guns, is also increasing. Perforating guns are not only essential for optimizing production but also play a key role in reducing downtime and improving the overall economics of well operations.

How Are Industry Trends and Environmental Considerations Shaping the Perforating Guns Market?

Industry trends, particularly the growing focus on cost-efficiency and environmental sustainability, are shaping the future of the perforating guns market. Oil and gas companies are increasingly seeking perforating technologies that enhance well productivity while reducing environmental impact. As a result, there is growing demand for reusable and modular perforating guns that can be deployed multiple times, reducing waste and lowering operational costs. Additionally, advancements in high-performance shaped charges are minimizing the amount of explosives used during perforation, which helps reduce the environmental footprint of well completions. The shift toward digitalization and automation in oil and gas operations is also influencing the market, with electronic detonation systems becoming more popular due to their precision, reliability, and ability to integrate with other downhole technologies. Furthermore, the rising adoption of unconventional drilling techniques, such as horizontal drilling and fracking, is driving demand for advanced perforating systems that can handle complex well geometries and high pressures. As environmental regulations become stricter, the industry’s focus on sustainable and efficient perforating solutions will continue to grow.

What Factors Are Driving Growth in the Perforating Guns Market?

The growth in the perforating guns market is driven by several factors, including technological advancements, increasing global demand for oil and gas, and the expansion of unconventional drilling operations. One of the main drivers is the development of advanced perforating technologies that improve well productivity and operational efficiency. The rising adoption of electronic detonation systems and reusable perforating guns is also contributing to market growth, as these technologies reduce costs and improve safety during well completions. Additionally, the global shift toward unconventional drilling methods, such as hydraulic fracturing in shale formations, is fueling demand for high-performance perforating guns capable of handling complex well environments. The growing focus on environmental sustainability and the need to comply with stricter regulations are prompting oil and gas companies to invest in perforating systems that minimize environmental impact while maximizing resource extraction. As the energy industry continues to evolve, the perforating guns market is expected to expand, driven by these technological, environmental, and operational trends.

Select Competitors (Total 44 Featured) -

• Abbott Laboratories
• AMG International
• Asahi Intecc Co., Ltd.
• B. Braun Melsungen AG
• Biosensors International Group Ltd.
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• BrosMed Medical Co., Ltd.
• Claret Medical
• Comed B.V.
• Contego Medical, LLC
• Cordis Corporation
• Elixir Medical Corporation
• EPflex Feinwerktechnik GmbH
• GaltNeedleTech
• Lepu Mdicial Technology (Beijing) Co., Ltd
• Medtronic PLC
• Meril Life Sciences Pvt., Ltd.
• Merit Medical Systems, Inc.
• OptiMed Medizinische Instrumente GmbH
• OrbusNeich
• Penumbra, Inc.
• RONTIS
• SP Medical A/S
• Stentys SA
• Teleflex Inc.
• Terumo Medical Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Percutaneous Coronary Intervention (PCI) Devices - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Cardiovascular Diseases (CVD) Drives Growth in Percutaneous Coronary Intervention (PCI) Devices Market
  • Technological Advancements in Drug-Eluting Stents (DES) Improve Long-Term Outcomes and Spur Market Growth
  • Increasing Adoption of Minimally Invasive Procedures Propels Demand for PCI Devices in Cardiac Interventions
  • Rising Use of Bioresorbable Stents Expands Market for Innovative, Temporary PCI Devices
  • Technological Innovations in Intravascular Imaging Systems (OCT and IVUS) Enhance Precision in PCI Procedures
  • Growing Focus on Robotic-Assisted PCI Systems Strengthens the Business Case for High-Precision Cardiac Interventions
  • Increased Demand for Next-Generation Balloon Catheters Expands Market for Advanced PCI Tools
  • Rising Adoption of PCI Devices in Treating Acute Coronary Syndromes (ACS) Expands Clinical Applications
  • Technological Advancements in Antithrombotic Devices and Drug-Coated Balloons Improve PCI Outcomes
  • Growing Focus on Outpatient and Ambulatory PCI Procedures Expands Market for Less Invasive Cardiac Devices
  • Rising Geriatric Population and High Prevalence of Coronary Artery Disease (CAD) Drive PCI Market Growth
  • Growing Emphasis on Personalized and Precision Medicine Fuels Development of Customized PCI Devices
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Percutaneous Coronary Intervention (PCI) Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for PTCA Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for PTCA Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for PTCA Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Catheterization Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Catheterization Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Catheterization Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 23: USA Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: USA 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
  • TABLE 26: USA Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: Canada 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
• JAPAN
  • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: Japan 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Japan Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: Japan 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
• CHINA
  • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 41: China Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: China 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
  • TABLE 44: China Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: China Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: China 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
• EUROPE
  • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
• FRANCE
  • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 56: France Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: France 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
  • TABLE 59: France Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: France Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: France 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
• GERMANY
  • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: Germany 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Germany Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: Germany 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: Italy 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Italy Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: Italy 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 74: UK Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: UK 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
  • TABLE 77: UK Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 78: UK Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: UK 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Rest of Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: Rest of Europe 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
  • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Rest of Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: Rest of Europe 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Asia-Pacific Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: Asia-Pacific 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
  • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Asia-Pacific Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: Asia-Pacific 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Rest of World Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: Rest of World 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
  • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Rest of World Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 97: Rest of World 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030

IV. COMPETITION